KATHMANDU: Glaxo Smith Kline (GSK), and Save the Children (SC) today in London launched a $1 million Healthcare Innovation Award to identify and reward innovations in healthcare which have proven successful in reducing child deaths in developing countries.
According to the communiqué issued today by both organisations, organisations from across the developing world can nominate examples of innovative healthcare approaches they have discovered or implemented. The deadline for nomination is 26 August.
These approaches must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicated.
Co-chaired by Sir Andrew Witty, CEO of GSK, and Justin Forsyth, CEO of Save the Children, the Judging Panel, made up of experts from the fields of public health, science and academia, will award $250,000 to the best healthcare innovation to further progress their work. An additional $750,000 will be made available for runners-up awards.
The award will also provide a platform for winning organisations to showcase their innovations and share information to enable others with an interest in improving healthcare to adapt and replicate successful interventions and create more positive change for children in their own country and beyond.